Sanguine Home
Products News Management Investors About Us
> medical applications | additional applications


spacer.gif (49 bytes)
Characteristics of PFCs
The utility of perfluorocarbon products was first recognized in World War II when the Manhattan Project (development of the atom bomb) required a chemically inert molecule for use with highly sensitive components. Scientists discovered that replacing hydrogen atoms of carbohydrates with fluorine produces fluorocarbons that are resistant to any kind of reaction with other molecules. Because fluorocarbon molecules are chemically inert, their reactions with surrounding molecules are limited to interactions of their physical properties such as relatively high vapor pressure and low boiling point, low surface tension, low viscosity, very low solubility in water, low solubility in oil, and increased solubility of gasses. The medical world was attracted to these characteristics because gaseous molecules seemed to stay imbedded in chemically inert PFCs significantly more than in corresponding carbohydrates. The volatility of some of the PFC molecules precluded use with humans. Compatible molecules, however, demonstrated the ability to convey oxygen at twice the rate of whole blood at normal body temperature. Retention of other gasses (CO2, N2, NO, and CO) are also significantly increased in PFCs and this suggest some interesting applications other than their oxygen-retention capabilities. PFCs are also of interest for medical uses because they are chemically inert, and thus do not react with other molecules. PFC products can also be sterilized and thus made completely free of contaminants, such as infectious viruses and bacteria.

Perfluorocarbons are not soluble in water, and therefore not soluble in blood. In order to be blood compatible, PFCs must be combined with a surfactant to form an emulsion that can be conveyed safely by the blood stream. Emulsions however, are not without problems. An emulsion can alter the PFCs’ properties. A clinically usable product requires development of a stable emulsion. Additionally, emulsions have only limited concentrations of PFC, meaning that the total PFC carried in the bloodstream is reduced, and therefore, the total volume of gas carried is also reduced. As attractive as PFCs are, they remain less efficient carriers of oxygen than hemoglobins (red blood cells) because their oxygen carrying ability is directly related to the inspired fraction of oxygen, nominally 20% of air taken into the lungs.

 

« back

 

line.gif (41 bytes)
Copyright 2001 Sanguine Corp. Products | News | Management | Investors | About Us